Wikidata

(Q61980807)

English

The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase I-II Trial of the Anti CD74 Monoclonal Antibody-Milatuzumab as a Single Agent in Refractory Chronic Lymphocytic Leukemia (English)
0 references
country
Israel
0 references
start time
April 2009
0 references
end time
April 2011
0 references
number of participants
15
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980807&oldid=2149382022"